|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
45,510,000 |
Market
Cap: |
17.34(B) |
Last
Volume: |
20,609,857 |
Avg
Vol: |
7,166,425 |
52
Week Range: |
$381.02 - $381.02 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile ABIOMED is a provider of medical devices that provide circulatory support and oxygenation. Co.'s existing products include: Impella 2.5®, which is a percutaneous heart pump with a motor and sensors; Impella CP®, which is primarily used by either interventional cardiologists to support patients in the cath lab or by cardiac surgeons in the heart surgery suite; Impella 5.0® and Impella LD®, which are percutaneous heart pumps with motors and sensors for use primarily in the heart surgery suite; Impella 5.5®, which is designed to be a percutaneous heart pump with motors and sensors; and Abiomed Breethe OXY-1 System, which is a portable external respiratory assistance device.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
17,044 |
Total Sell Value |
$0 |
$0 |
$0 |
$5,919,264 |
Total People Sold |
0 |
0 |
0 |
5 |
Total Sell Transactions |
0 |
0 |
0 |
10 |
End Date |
2024-03-21 |
2023-12-19 |
2023-06-20 |
2022-06-20 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Sutter Martin P |
Director |
|
2022-02-17 |
4 |
S |
$307.64 |
$1,258,852 |
D/D |
(4,000) |
130,390 |
|
16% |
|
Rolle Myron L |
Director |
|
2022-02-17 |
4 |
D |
$325.42 |
$36,447 |
D/D |
(112) |
1,303 |
|
- |
|
Sutter Martin P |
Director |
|
2022-02-16 |
4 |
AS |
$295.55 |
$617,322 |
D/D |
(2,000) |
134,390 |
|
-23% |
|
Weber David M |
Chief Operating Officer |
|
2022-02-16 |
4 |
AS |
$325.00 |
$2,437,500 |
D/D |
(7,500) |
123,814 |
|
-23% |
|
Sutter Martin P |
Director |
|
2022-02-15 |
4 |
AS |
$296.18 |
$607,301 |
D/D |
(2,000) |
136,390 |
|
-16% |
|
Weber David M |
Chief Operating Officer |
|
2022-02-09 |
4 |
AS |
$310.19 |
$965,311 |
D/D |
(3,112) |
131,314 |
|
-26% |
|
Weber David M |
Chief Operating Officer |
|
2022-02-09 |
4 |
OE |
$21.55 |
$67,064 |
D/D |
3,112 |
134,426 |
|
- |
|
Weber David M |
Chief Operating Officer |
|
2022-02-08 |
4 |
AS |
$300.40 |
$2,245,423 |
D/D |
(7,413) |
131,314 |
|
-26% |
|
Weber David M |
Chief Operating Officer |
|
2022-02-08 |
4 |
OE |
$21.55 |
$159,750 |
D/D |
7,413 |
138,727 |
|
- |
|
Weber David M |
Chief Operating Officer |
|
2022-02-07 |
4 |
AS |
$300.25 |
$90,076 |
D/D |
(300) |
131,314 |
|
-22% |
|
Weber David M |
Chief Operating Officer |
|
2022-02-07 |
4 |
OE |
$21.55 |
$6,465 |
D/D |
300 |
131,614 |
|
- |
|
Trapp Todd A |
Vice President, CFO |
|
2022-01-05 |
4 |
AS |
$359.43 |
$359,430 |
D/D |
(1,000) |
14,063 |
|
-25% |
|
Sutter Martin P |
Director |
|
2021-11-18 |
4 |
AS |
$336.06 |
$5,078,787 |
D/D |
(15,000) |
138,390 |
|
-0% |
|
Sutter Martin P |
Director |
|
2021-11-17 |
4 |
AS |
$342.65 |
$1,293,573 |
D/D |
(3,750) |
153,390 |
|
-4% |
|
Sutter Martin P |
Director |
|
2021-11-16 |
4 |
AS |
$346.86 |
$1,319,448 |
D/D |
(3,750) |
157,140 |
|
-7% |
|
Began Marc A |
VP & General Counsel |
|
2021-11-06 |
4 |
D |
$361.71 |
$54,980 |
D/D |
(152) |
11,159 |
|
- |
|
Weber David M |
Chief Operating Officer |
|
2021-11-03 |
4 |
D |
$349.76 |
$541,778 |
D/D |
(1,549) |
131,314 |
|
- |
|
Weber David M |
Chief Operating Officer |
|
2021-11-03 |
4 |
A |
$0.00 |
$0 |
D/D |
6,975 |
132,863 |
|
- |
|
Greenfield Andrew J |
VP, Chief Commercial Officer |
|
2021-11-03 |
4 |
D |
$349.76 |
$541,778 |
D/D |
(1,549) |
43,220 |
|
- |
|
Greenfield Andrew J |
VP, Chief Commercial Officer |
|
2021-11-03 |
4 |
A |
$0.00 |
$0 |
D/D |
6,975 |
44,769 |
|
- |
|
Began Marc A |
VP & General Counsel |
|
2021-11-03 |
4 |
D |
$349.76 |
$541,778 |
D/D |
(1,549) |
11,311 |
|
- |
|
Began Marc A |
VP & General Counsel |
|
2021-11-03 |
4 |
A |
$0.00 |
$0 |
D/D |
6,975 |
12,860 |
|
- |
|
Trapp Todd A |
Vice President, CFO |
|
2021-11-03 |
4 |
D |
$349.76 |
$541,778 |
D/D |
(1,549) |
15,063 |
|
- |
|
Trapp Todd A |
Vice President, CFO |
|
2021-11-03 |
4 |
A |
$0.00 |
$0 |
D/D |
6,975 |
16,612 |
|
- |
|
Minogue Michael R |
Chairman, President, CEO |
|
2021-11-03 |
4 |
D |
$349.76 |
$1,804,062 |
D/D |
(5,158) |
229,763 |
|
- |
|
1353 Records found
|
|
Page 4 of 55 |
|
|